
The study hypothesised that ER‐CA would result in a lower risk of cardiovascular hospitalisation and death versus DS‐CA in this population. In patients with persistent AF and HF, ER‐CA produces similar long‐term outcomes to a DS‐CA strategy. The association between CA as a treatment‐received and improved outcomes means there is still a lack of clarity regarding the role of early CA in selected patients. Randomised trials are needed to clarify this question.
Like
Save
Share